Total Payments
$985.42
2024 Payments
$178.18
Companies
17
Transactions
55
Medicare Patients
951
Medicare Billing
$81,138
Payment Breakdown by Category
Food & Beverage$985.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $985.42 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $336.28 | 18 | $0 (2024) |
| Boston Scientific Corporation | $121.88 | 2 | $0 (2024) |
| Lilly USA, LLC | $104.30 | 7 | $0 (2024) |
| Amgen Inc. | $82.76 | 4 | $0 (2019) |
| PFIZER INC. | $54.10 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $45.85 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.96 | 3 | $0 (2018) |
| Genentech USA, Inc. | $32.80 | 2 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $28.69 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $26.71 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178.18 | 6 | Novo Nordisk Inc ($110.40) |
| 2023 | $97.55 | 5 | Novo Nordisk Inc ($43.65) |
| 2022 | $119.73 | 2 | Boston Scientific Corporation ($105.52) |
| 2021 | $44.88 | 3 | Novo Nordisk Inc ($29.69) |
| 2019 | $285.55 | 21 | Novo Nordisk Inc ($109.29) |
| 2018 | $170.16 | 11 | Novo Nordisk Inc ($43.25) |
| 2017 | $89.37 | 7 | Takeda Pharmaceuticals America, Inc. ($20.53) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $87.64 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Obesity | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Obesity | ||||||
| 04/16/2024 | W. L. Gore & Associates, Inc. | GORE ENFORM Preperitoneal Biomaterial (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Devices | ||||||
| 03/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/27/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Obesity | ||||||
| 08/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Obesity | ||||||
| 03/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Oncology | ||||||
| 06/30/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 03/29/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $105.52 | General |
| Category: WATCHMAN_IC | ||||||
| 07/28/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Obesity | ||||||
| 05/25/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: VACCINES | ||||||
| 05/21/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Obesity | ||||||
| 09/05/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Neuroscience | ||||||
| 08/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Diabetes | ||||||
| 08/12/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/18/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: VACCINES | ||||||
| 07/02/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 06/17/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
| 06/05/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: VACCINES | ||||||
| 06/04/2019 | Lilly USA, LLC | HUMALOG (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Diabetes | ||||||
| 05/20/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 31 | $4,247 | $1,627 |
| 2022 | 2 | 181 | 246 | $38,299 | $14,545 |
| 2021 | 6 | 358 | 566 | $102,225 | $34,225 |
| 2020 | 8 | 397 | 634 | $109,188 | $30,742 |
Total Patients
951
Total Services
1,477
Medicare Billing
$81,138
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 31 | $4,247 | $1,627 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 228 | $31,234 | $11,669 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $7,066 | $2,876 | 40.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 215 | 421 | $79,148 | $24,028 | 30.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 50 | 50 | $3,350 | $3,322 | 99.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 14 | 14 | $7,546 | $2,482 | 32.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 12 | $6,120 | $1,947 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 17 | $4,709 | $1,603 | 34.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 52 | 52 | $1,352 | $842.92 | 62.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 211 | 442 | $83,096 | $20,650 | 24.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 48 | 48 | $3,072 | $2,867 | 93.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 24 | $6,648 | $2,080 | 31.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 12 | 14 | $7,140 | $2,054 | 28.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $6,848 | $1,810 | 26.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 54 | 54 | $1,404 | $856.69 | 61.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 22 | 23 | $597.00 | $215.21 | 36.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $383.00 | $209.25 | 54.6% |
About Abby Reich
Abby Reich is a Pediatrics healthcare provider based in Quincy, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700966124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abby Reich has received a total of $985.42 in payments from pharmaceutical and medical device companies, with $178.18 received in 2024. These payments were reported across 55 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($985.42).
As a Medicare-enrolled provider, Reich has provided services to 951 Medicare beneficiaries, totaling 1,477 services with total Medicare billing of $81,138. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Quincy, IL
- Active Since 10/17/2006
- Last Updated 12/09/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1700966124
Products in Payments
- Wegovy (Drug) $171.61
- WATCHMAN Access System (Device) $105.52
- Ozempic (Drug) $74.34
- Aimovig (Biological) $68.20
- Tresiba (Drug) $63.22
- BEXSERO (Biological) $45.85
- Amitiza (Drug) $45.34
- REXULTI (Drug) $28.69
- Saxenda (Drug) $27.11
- HUMULIN (Drug) $27.10
- LYRICA (Drug) $25.50
- FARXIGA (Drug) $20.50
- ZEPBOUND (Drug) $20.44
- Cologuard Collection Kit (Device) $19.83
- GORE ENFORM Preperitoneal Biomaterial (Device) $17.52
- TRADJENTA (Drug) $17.48
- Xofluza (Drug) $17.32
- PREVNAR - 13 (Biological) $15.80
- Xolair (Biological) $15.48
- Repatha (Biological) $14.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Quincy
Richard Schlepphorst, Md, MD
Pediatrics — Payments: $3,005
Pediatrics $3,005
Dr. Ana Markovic, Md, MD
Pediatrics — Payments: $1,072
Pediatrics $1,072
Dr. Lindsay Brink, D.o, D.O
Pediatrics — Payments: $1,014
Pediatrics $1,014
Alicia Fernandez-Garcia, M.d, M.D
Pediatrics — Payments: $759.11
Pediatrics $759.11
Dr. Samuel Healy, D.o, D.O
Pediatrics — Payments: $498.12
Pediatrics $498.12
Charone Tolbert, Md, MD
Pediatrics — Payments: $481.00
Pediatrics $481.00